# Repligen Corp.

Type: Company (RGEN)

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/repligen-corp
Canonical HTML page: https://getbiobrief.com/entity/repligen-corp

## Recent coverage (1 stories)

### Biolife’s $1B+ Takeover Potential Reshapes Cell Therapy Supply Chains
2026-06-27 23:07:17 · Sentiment: Positive · Impact: 7/10 · Sources: 2

Repligen’s reported interest in Biolife Solutions could create a bioprocessing-to-cryopreservation powerhouse. For the biotech industry, this deal promises an integrated supplier but raises concerns about supplier consolidation as the cell and gene therapy market expands at over 20% CAGR.
Full story: https://getbiobrief.com/story/biolife-repligen-takeover-cell-therapy-supply-chain

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.